Use of Novel High-protein Food Products To Reduce Insulin Resistance
NCT ID: NCT02851498
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2015-01-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Starch and Whey Protein on Energy Metabolism
NCT02418429
Nutrient Synergy in Beef and Stimulation of Protein Synthesis in Elderly
NCT01415973
Protein Intake & Insulin Action
NCT02004002
Role of Glycaemic Index and High Protein Meal in Response of Blood Biomarkers for Pre-diabetes
NCT03309254
A Study of Biochemical Response to Alternative Proteins
NCT06253728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Novel high-protein pasta and cereal
High-protein pasta (orzo and fusilli) enriched with gluten and egg white protein (%energy: 27/30/43 for protein/fat/carbohydrate) and high-protein flaked breakfast cereal enriched with gluten (%energy: 30/35/35 for protein/fat/carbohydrate) were manufactured by Zone Inc.(Boston, MA). The study foods provided an average of 945 kcal/day (one aliquot of cereal and two pasta dishes daily). Pasta meals were prepared in a metabolic kitchen and were identical in appearance and basic taste as control meals.
Food product: high-protein pasta and cereal
Control pasta and cereal
Commercial gluten-free pasta (Barcilla orzo and fusilli; %energy: 13/24/63 for protein/fat/carbohydrate) and commercial flaked cereal (Post Honey Bunches of Oats; %energy: 6/18/76 for protein/fat/carbohydrate) were used as the control foods. The study foods provided an average of 945 kcal/day (one aliquot of cereal and two pasta dishes daily). Pasta meals were prepared in a metabolic kitchen and were identical in appearance and basic taste as experimental foods.
Food product: high-protein pasta and cereal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Food product: high-protein pasta and cereal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 23-42 kg/m2
Exclusion Criteria
* diet restrictions (e.g., vegetarian, gluten or lactose intolerant)
* insulin use
* cigarette use
* active disease states including diagnosed diabetes
* anticipated changes to diet or physical activity levels
* recent weight gain or loss (±10 pounds)
* current or recent pregnancy or lactation
* prescription medication use by participants was allowed if use had been consistent
20 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inflammation Research Foundation
UNKNOWN
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carol Johnston
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ArizonaSU2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.